Cargando…
Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®
BACKGROUND: Vaccination-impact studies of the live-attenuated pentavalent oral vaccine Rotateq® have demonstrated that the burden of rotavirus gastroenteritis has been reduced significantly after the introduction of RotaTeq® vaccination, but less is known about the benefit of this vaccination on hos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266892/ https://www.ncbi.nlm.nih.gov/pubmed/25494641 http://dx.doi.org/10.1186/s12913-014-0632-z |
_version_ | 1782349072609312768 |
---|---|
author | Hartwig, Susanne Uhari, Matti Renko, Marjo Bertet, Perrine Hemming, Maria Vesikari, Timo |
author_facet | Hartwig, Susanne Uhari, Matti Renko, Marjo Bertet, Perrine Hemming, Maria Vesikari, Timo |
author_sort | Hartwig, Susanne |
collection | PubMed |
description | BACKGROUND: Vaccination-impact studies of the live-attenuated pentavalent oral vaccine Rotateq® have demonstrated that the burden of rotavirus gastroenteritis has been reduced significantly after the introduction of RotaTeq® vaccination, but less is known about the benefit of this vaccination on hospital overcrowding. METHODS: As part of an observational surveillance conducted during the RV seasons 2000/2001 to 2011/2012, we analysed hospital discharge data collected retrospectively from two Finnish hospitals (Oulu and Tampere), concerning ICD 10 codes A00-09 (acute gastroenteritis, AGE) and A08.0 (rotaviral acute gastroenteritis RV AGE). We estimated the reduction in the number of beds occupied and analysed the bed occupancy rate, for RV AGE and all cause AGE, among 0–16 year-old children, before and after the implementation of the RV immunisation program. RESULTS: The rate of bed days occupied for RV AGE was reduced by 86% (95% CI 66%-94%) in Tampere and 79% (95% CI 47%-92%) in Oulu after RV vaccination implementation. For all cause AGE, reduction was 50% (95% CI 29% to 65%) in Tampere and 70% (95% CI 58% to 79%) in Oulu. Results were similar among 0–2 year-old children. This effect was also observed on overcrowding in both hospitals, with a bed occupancy rate for all cause AGE >25% in only 1% of the time in Tampere and 9% in Oulu after the implementation of the immunisation program, compared to 13% and 48% in the pre-vaccination period respectively. After extrapolation to the whole country, the annual number of prevented hospitalizations for all cause AGE in the post-vaccination period in Finland was estimated at 1,646 and 2,303 admissions for 0–2 and 0–16 year-old children respectively. CONCLUSIONS: This study demonstrated that universal RV vaccination is associated with a clear decrease in the number of bed days and occupancy rates for RV AGE and all cause AGE. Positive consequences include increase in quality of care and a better healthcare management during winter epidemics. |
format | Online Article Text |
id | pubmed-4266892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42668922014-12-16 Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® Hartwig, Susanne Uhari, Matti Renko, Marjo Bertet, Perrine Hemming, Maria Vesikari, Timo BMC Health Serv Res Research Article BACKGROUND: Vaccination-impact studies of the live-attenuated pentavalent oral vaccine Rotateq® have demonstrated that the burden of rotavirus gastroenteritis has been reduced significantly after the introduction of RotaTeq® vaccination, but less is known about the benefit of this vaccination on hospital overcrowding. METHODS: As part of an observational surveillance conducted during the RV seasons 2000/2001 to 2011/2012, we analysed hospital discharge data collected retrospectively from two Finnish hospitals (Oulu and Tampere), concerning ICD 10 codes A00-09 (acute gastroenteritis, AGE) and A08.0 (rotaviral acute gastroenteritis RV AGE). We estimated the reduction in the number of beds occupied and analysed the bed occupancy rate, for RV AGE and all cause AGE, among 0–16 year-old children, before and after the implementation of the RV immunisation program. RESULTS: The rate of bed days occupied for RV AGE was reduced by 86% (95% CI 66%-94%) in Tampere and 79% (95% CI 47%-92%) in Oulu after RV vaccination implementation. For all cause AGE, reduction was 50% (95% CI 29% to 65%) in Tampere and 70% (95% CI 58% to 79%) in Oulu. Results were similar among 0–2 year-old children. This effect was also observed on overcrowding in both hospitals, with a bed occupancy rate for all cause AGE >25% in only 1% of the time in Tampere and 9% in Oulu after the implementation of the immunisation program, compared to 13% and 48% in the pre-vaccination period respectively. After extrapolation to the whole country, the annual number of prevented hospitalizations for all cause AGE in the post-vaccination period in Finland was estimated at 1,646 and 2,303 admissions for 0–2 and 0–16 year-old children respectively. CONCLUSIONS: This study demonstrated that universal RV vaccination is associated with a clear decrease in the number of bed days and occupancy rates for RV AGE and all cause AGE. Positive consequences include increase in quality of care and a better healthcare management during winter epidemics. BioMed Central 2014-12-11 /pmc/articles/PMC4266892/ /pubmed/25494641 http://dx.doi.org/10.1186/s12913-014-0632-z Text en © Hartwig et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hartwig, Susanne Uhari, Matti Renko, Marjo Bertet, Perrine Hemming, Maria Vesikari, Timo Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® |
title | Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® |
title_full | Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® |
title_fullStr | Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® |
title_full_unstemmed | Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® |
title_short | Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® |
title_sort | hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two finnish hospitals before and after the implementation of the national rotavirus vaccination program with rotateq® |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266892/ https://www.ncbi.nlm.nih.gov/pubmed/25494641 http://dx.doi.org/10.1186/s12913-014-0632-z |
work_keys_str_mv | AT hartwigsusanne hospitalbedoccupancyforrotavirusandallcauseacutegastroenteritisintwofinnishhospitalsbeforeandaftertheimplementationofthenationalrotavirusvaccinationprogramwithrotateq AT uharimatti hospitalbedoccupancyforrotavirusandallcauseacutegastroenteritisintwofinnishhospitalsbeforeandaftertheimplementationofthenationalrotavirusvaccinationprogramwithrotateq AT renkomarjo hospitalbedoccupancyforrotavirusandallcauseacutegastroenteritisintwofinnishhospitalsbeforeandaftertheimplementationofthenationalrotavirusvaccinationprogramwithrotateq AT bertetperrine hospitalbedoccupancyforrotavirusandallcauseacutegastroenteritisintwofinnishhospitalsbeforeandaftertheimplementationofthenationalrotavirusvaccinationprogramwithrotateq AT hemmingmaria hospitalbedoccupancyforrotavirusandallcauseacutegastroenteritisintwofinnishhospitalsbeforeandaftertheimplementationofthenationalrotavirusvaccinationprogramwithrotateq AT vesikaritimo hospitalbedoccupancyforrotavirusandallcauseacutegastroenteritisintwofinnishhospitalsbeforeandaftertheimplementationofthenationalrotavirusvaccinationprogramwithrotateq |